NTRA: Natera, Inc. Stock

SIC 8071 – Medical Laboratories

Valuation
Market Cap ($M) 22,245.51
Enterprise Value ($M) 21,719.68
Book Value ($M) 878.52
Book Value / Share 6.65
Price / Book 25.32
NCAV ($M) 610.14
NCAV / Share 4.62
Price / NCAV 36.46

Profitability (mra)
Return on Invested Capital (ROIC) -0.16
Return on Assets (ROA) -0.15
Return on Equity (ROE) -0.28

Liquidity (mrq)
Quick Ratio 4.23
Current Ratio 4.39

Balance Sheet (mrq) ($M)
Current Assets 1,322.57
Assets 1,590.95
Liabilities 712.42
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Alger Associates Inc 3.20 -43.30
11-08 13G/A BlackRock, Inc. 6.70 0.00
06-07 13G/A Jpmorgan Chase & Co 4.30 -33.01
02-13 13G/A Vanguard Group Inc 9.13 10.32

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-21 257,401 1,714,908 15.01
2025-01-17 384,852 1,997,110 19.27
2025-01-16 197,854 776,047 25.50

(click for more detail)

Similar Companies
FTRE – Fortrea Holdings Inc. GH – Guardant Health, Inc.


Financial data and stock pages provided by
Fintel.io